-
Mundipharma and Manchester City team up in sponsorship deal
Manchester, UK, 29th September 2016 / Sciad Newswire / Pharmaceutical firm Mundipharma and Premier League club Manchester City have announced that they have entered into a three-year partnership to strengthen their relationship with fans and consumers across the globe, and harness the popularity of football to raise public awareness of key health issues such as the importance of staying healthy. Raman Singh,…
-
Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016
London, UK, 7th October 2016 / Sciad Newswire / SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held last night. The OBN Awards celebrate innovation and achievement across the UK life sciences industry, including emerging to late stage R&D companies as well as life science investors. Touchlight Genetics, a…
-
Riffyn Launches Process Design and Data Analytics Software at SynBioBeta 2016
San Francisco, USA, 4th October 2016 / Sciad Newswire / Riffyn announced today the launch of its cloud-based research process design software at the SynBioBeta SF 2016 conference. The launch follows a successful beta trial period, in which more than 40 organizations participated. Riffyn’s product delivers a step-change in the pace and quality of research and development in the life science,…
-
Fifty Years Launches New VC Fund Aimed At Furthering The Millennium Sustainable Development Goals
San Francisco, USA, 4th October 2016 / Sciad Newswire / Fifty Years is a new VC fund based in Silicon Valley that funds entrepreneurs using technology to solve the world’s biggest problems. Like a traditional VC fund, Fifty Years looks for companies with the potential to turn into massive businesses. Unlike most, it also looks for companies that, if successful, will solve…
-
SGI-DNA Announces Commercial Launch of Syn2.0™ and Syn3.0™ Minimal Synthetic Cells
La Jolla, California, United States, 5th Month 2016 / Sciad Newswire / SGI-DNA, a Synthetic Genomics, Inc. company, announced today that it is making Syn2.0™ and Syn3.0™ Minimal Synthetic Cells commercially available to researchers worldwide. With genomes smaller than any known naturally occurring bacterium, Syn2.0™ and Syn3.0™ Minimal Synthetic Cells have many potential research applications including elucidating essential gene function, serving as…
-
Bio-start Confirms Sir Richard Sykes as Chair of Judging Panel
SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial College Healthcare and Chancellor of Brunel University, will act as Chair of judges for the Bio-start competition judging panel in 2017.
-
How do we Build Better Genes, Proteins & Pathways to Genomes?
San Francisco, USA, 4th October 2016 / Sciad Newswire / Biologist and inventor of new transposase-based tool, Kate Caves discusses DNA2.0’s emerging cell engineering capabilities at SynBioBeta. DNA2.0 Inc., a pioneer in bioengineering solutions, recently announced the issuance of a genomic modification patent for an innovative transposon- and transposase-based tool that, combined with the company’s industrial scale gene synthesis…
-
Ecovative Launches New Line of Biofabricated Furniture for the Home Fully Grown From Mushroom® Materials
Ecovative Design, the pioneer and world leader in the biofabrication of mycelium-based products, is launching a new line of first-of-its-kind, fully grown, mushroom-based furniture—beginning with the Imperial Stool—that is healthy and sustainable.
-
ReViral Announces Appointment of New Chief Executive Officer
ReViral Ltd, a biotechnology company, aiming to help patients infected with respiratory syncytial virus (RSV) by developing novel compounds, is pleased to announce the appointment of Eddy Littler as CEO.
-
ProAxsis Gains CE Mark for Active Neutrophil Elastase Immunoassay
ProAxsis Limited is pleased to announce that it has successfully registered a CE Mark for its novel ProteaseTag® Active Neutrophil Elastase Immunoassay.